Alterity Therapeutics Limited Stock Market Value

PRNAF Stock  USD 0  0.00  0.00%   
Alterity Therapeutics' market value is the price at which a share of Alterity Therapeutics trades on a public exchange. It measures the collective expectations of Alterity Therapeutics Limited investors about its performance. Alterity Therapeutics is trading at 0.0036 as of the 29th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.0036.
With this module, you can estimate the performance of a buy and hold strategy of Alterity Therapeutics Limited and determine expected loss or profit from investing in Alterity Therapeutics over a given investment horizon. Check out Alterity Therapeutics Correlation, Alterity Therapeutics Volatility and Alterity Therapeutics Alpha and Beta module to complement your research on Alterity Therapeutics.
For more detail on how to invest in Alterity Pink Sheet please use our How to Invest in Alterity Therapeutics guide.
Symbol

Please note, there is a significant difference between Alterity Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alterity Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alterity Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Alterity Therapeutics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alterity Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alterity Therapeutics.
0.00
10/30/2024
No Change 0.00  0.0 
In 31 days
11/29/2024
0.00
If you would invest  0.00  in Alterity Therapeutics on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding Alterity Therapeutics Limited or generate 0.0% return on investment in Alterity Therapeutics over 30 days. Alterity Therapeutics is related to or competes with Genprex, Reviva Pharmaceuticals, Greenwich Lifesciences, Cognition Therapeutics, Galectin Therapeutics, Northwest Biotherapeutics, and CEL SCI. Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimers disease, ... More

Alterity Therapeutics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alterity Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alterity Therapeutics Limited upside and downside potential and time the market with a certain degree of confidence.

Alterity Therapeutics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Alterity Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alterity Therapeutics' standard deviation. In reality, there are many statistical measures that can use Alterity Therapeutics historical prices to predict the future Alterity Therapeutics' volatility.
Hype
Prediction
LowEstimatedHigh
0.0000.00
Details
Intrinsic
Valuation
LowRealHigh
0.0000.00
Details
Naive
Forecast
LowNextHigh
000
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Alterity Therapeutics. Your research has to be compared to or analyzed against Alterity Therapeutics' peers to derive any actionable benefits. When done correctly, Alterity Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Alterity Therapeutics.

Alterity Therapeutics Backtested Returns

We have found three technical indicators for Alterity Therapeutics Limited, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Alterity Therapeutics are completely uncorrelated.

Auto-correlation

    
  1.00  

Perfect predictability

Alterity Therapeutics Limited has perfect predictability. Overlapping area represents the amount of predictability between Alterity Therapeutics time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alterity Therapeutics price movement. The serial correlation of 1.0 indicates that 100.0% of current Alterity Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient1.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0

Alterity Therapeutics lagged returns against current returns

Autocorrelation, which is Alterity Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Alterity Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Alterity Therapeutics returns to help us make a trade decision. For example, suppose you find that Alterity Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Alterity Therapeutics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Alterity Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Alterity Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Alterity Therapeutics pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Alterity Therapeutics Lagged Returns

When evaluating Alterity Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Alterity Therapeutics pink sheet have on its future price. Alterity Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Alterity Therapeutics autocorrelation shows the relationship between Alterity Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Alterity Therapeutics Limited.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Alterity Pink Sheet

Alterity Therapeutics financial ratios help investors to determine whether Alterity Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alterity with respect to the benefits of owning Alterity Therapeutics security.